420 with CNW – California Marijuana Industry Workers Move to Unionize

California has made it easy for weed workers to join labor unions after Governor Gavin Newsom on Friday signed into law a bill that requires all cannabis stores that have 20 employees or more to enter into labor peace agreements.

California is the second state (after New York) to issue a requirement for licensed weed shops to enter into a peace deal with the labor union whereby they promise not to stop their employees from joining a union. This agreement will discourage workers from organizing labor strikes against the company.

In recent years, there has been an increased number of states decriminalizing marijuana, and this has prompted labor unions to push for these agreements. The labor union goal is to make sure that the 6 billion dollar industry does not take advantage of their workers who, instead of being paid proper wages, are paid below the minimum wage.

According to the United Food and Commercial Workers International Union (UFCW), the push for the agreements is a way for workers to form a labor union and boost their membership. When the cannabis workers are unionized, they can negotiate for better pay, annual pay rises, and health insurance coverage. UFCW is responsible for organizing marijuana workers in the U.S since 2011.

After voters approved the ballot measure for the legalization of recreational marijuana sales in 2016, California issued a requirement for all weed shops to sign the labor peace deal. However, the downside to this requirement was that the law did not include how the agreement would be enforced, nor the deadline for signing the contract by the marijuana businesses.

According to the new law signed on Friday, businesses are given a maximum of 60 days to sign the labor peace deal; if not, the employee can file a complaint with the state’s labor regulators.

A California Assembly member, Reggie Jones-Sawyer said that the signed law would help employees with clear information on when the employer is not complying with the law and when they should file a complaint.

The labor strategy being used by the emerging marijuana industry was once used to organize shipyard workers and casino employees.

Each labor deal varies from company to company, but the similarities are; the managers agree not to stop workers from joining unions, provide contact information of labor organizers to employees and give unions access to the workplace to meet with the employees. Meanwhile, the unions agree not to incite employees to go on a strike and not to say negative things about the employers to the workers.

When a marijuana company advertises the unionizing of its employees, it means that the business is a legal entity. Experts think this development in California will be welcomed by industry actors, such as Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF), since it puts marijuana industry workers at par with employees in other industries.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Researchers Call for Global Marijuana Dosage Standard Units

There are no widely accepted health guidelines for marijuana despite the increased moves by different states to legalize recreational cannabis and the widespread consumption of weed.

Addiction and Mental Health Group researchers from the University of Bath, in collaboration with UCL, Kings College London, and the Australian Catholic University in Melbourne, suggests that users should be educated on the dosages of THC, which is the component of the drug that is psychoactive (gets you high).

The team had conducted another research in 2018, which highlighted that over the past decade, the THC concentration in Europe doubled. When combined with this year’s study, which was published on 13^th October in the journal Addiction, the researchers suggest that the THC should be set at a unit level of 5mg.

In countries where recreational cannabis is sold legally, such as Canada, the set level of mg in a product could be easily added to existing labels on the product packet. However, this system could prove to be disadvantageous in countries where cannabis is illegal, such as the UK. The researchers suggested introducing an international system where users and doctors are given guidelines.

On October 13, another team of researchers published their findings in the journal of Psychological Medicine. Their study examined the relationship between using different products of cannabis and their health outcomes. Their study used more than 55,000 people in 175 countries.

Using the Global Drug Survey, the researchers asked the consumers about the various marijuana products consumed and the severity of the illnesses when they used weed as well as their mental health.

The results of the study varied according to the type of marijuana product used and the associated health outcome. For instance, those who use higher doses of THC such as hashish or sinsemilla experienced more severe problems, unlike those who consumed a lower dose of THC.

The difference between the types of marijuana products sold in the legal and illegal market has prompted the authors of the research to direct a team of experts to meet in Lisbon to develop a standardized tool that will be used for assessing marijuana in the international market. The Society for the Study of Addiction is funding the development of the standardized tool.

Sam Craft from King’s College London, who is the lead author of the study, said that their research finding adds to the growing body of evidence which concludes that the health effects of marijuana are dose-related. Although the risks can be modified, the introduction of a unified international system will equip the users and medical marijuana doctors with information on the different types of cannabis products being consumed, as well as their potency.

Dr. Tom Freeman from Bath University, who is the senior author, said that the research findings show that developing an evidence-based framework will help people consume marijuana more responsibly. The absence of updated information increases the level of risk to the consumers.

There are many people across the globe using weed, and it is our responsibility as researchers to help them make informed choices, although the best and safest option is not using at all, he added.

The researchers hope that the introduction of a unified system will help in reducing the adverse effects of marijuana use in different countries while providing doctors and consumers with information for the safer use of marijuana.

It would be interesting to hear what views cannabis industry companies like Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) have to say about how to develop standard units for marijuana.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Capitalizing on Adult-Use Cannabis Industry by Anticipating Market Movement

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a West Coast cannabis holding company, is focused on exploiting the adult-use cannabis industry by finding where the market is and anticipating where it’s going, especially in regards to technology. An article discussing the company reads, “IONIC Brands is developing a premium and luxury consumer portfolio led by a multistate, consumer-focused cannabis concentrate brand. Its base is on the West Coast, where the adult-recreational-use market for cannabis is booming with the largest volume of business in the world. . . . The company’s product line includes six cannabis formulations presented in three distinctive mood offerings designed to appeal to recreational users according to the consumers’ preferences for rich sociability, serene relaxation or enlightened creativity (http://cnw.fm/z06Vz).”

To view the full article, visit http://cnw.fm/2waFK

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused, cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is one of the top vaporizer brands in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – HTC Extraction Systems (TSX.V: HTC) Announces Repricing of “Bought Deal” Brokered Private Placement

HTC Extraction Systems (TSX.V: HTC) today announced that it has repriced its “bought deal” brokered private placement initially announced on July 3, 2019 and amended on September 27, 2019. According to the update, the repricing of the private placement more accurately reflects the current market price of the company’s common shares. Under the terms of the offering, Canaccord Genuity Corp. will act as sole bookrunner and lead underwriter, on behalf of a syndicate of underwriters, and purchase, on a “bought deal” private placement basis, 25,000,000 units of the company, each at a price of C$0.40, for aggregate gross proceeds of C$10,000,000.

To view the full press release, visit http://cnw.fm/PuWf4

About HTC Extraction Systems

HTC Extraction Systems has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced. For more information, visit the company’s website at www.HTCExtraction.com.

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://cnw.fm/HTC

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Achieves Record Revenues for Q1 Fiscal Year 2020

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today announced its financial and operational summary for the first quarter of its fiscal year 2020. According to the update, total revenue for Q1FY2020 was $1,956,960, which is a 174.7% increase from $712,360 for the same quarter in the prior year. In addition, hemp and CBD sales revenues for Q1FY2020 were $948,751, a 569.2% increase from $141,764 for the same quarter in the prior year. “Fiscal Year 2020 is off to a great start evidenced by continued growth in both the company’s core business and its industrial hemp/CBD product business,” CIIX CEO Warren Wang said in the news release. “Following the 2018 cryptocurrency crash, the company re-focused on its core business, including providing investor relations services for other companies, especially those requiring Mandarin language support, and continued to implement its strategic plans for expansion of CBD Biotechnology Co. Ltd.’s, industrial hemp/CBD product lines in China evidenced by new product launches and initiatives taken to expand geographically in the Asian market.”

To view the full press release, visit http://cnw.fm/b3oX3

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) Finalizes Liquid Formulation of Mustard-Derived Bio-Pesticide

MustGrow Biologics (CSE: MGRO) (OTC: MGROF), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides and bio-fertility products, this morning announced the finalization of its advanced liquid formulation. The new liquid formulation is an advancement of the company’s signature mustard-derived ‘granule format’ bio-pesticide product. In contrast to the granule format, the liquid formulation can be applied through standard drip or spray equipment and improves functionality and performance. Among other highlights, it has greater efficacy results per volume, a higher concentration of the active ingredient, and lower transportation costs. MustGrow’s liquid formulation work program was completed by National Research Council Canada (“NRC”). The NRC assessed control of hard-to-kill soil-borne diseases and application use-rates, especially diseases that have been challenging for many of Canada’s licensed cannabis producers. The NRC achieved 100% control of hard-to-kill soil borne diseases such as Botrytis and Fusarium using the company’s liquid formulation. Presently, MustGrow is undertaking additional testing to assess efficacy on other pests and further market applications in the food value chain, including storage container fumigation.

To view the full press release, visit http://cnw.fm/6vOeR

About MustGrow Biologics Corp.

MustGrow is a publicly traded (CSE: MGRO) (OTC: MGROF) agricultural biotech company focused on providing natural science-based biological solutions for cannabis and fruit & vegetable cultivation. In cannabis, the company is currently developing reliable, safe and biological solutions that adhere to Health Canada’s strict regulations. The company currently has three products suited for the cannabis market: a mustard-derived bio-pesticide, CannaProtector(R), to treat soil borne pests and diseases; a bio-fungicide, CannaVate(R), that can be used a foliar application for powdery mildew; and a bio-fertility product, TP-1000, to increase yield, THC and terpene levels. CannaVate(R) and TP-1000 are in-licenced products for which MustGrow has exclusive rights in Canada. CannaProtector(R) is based on MustGrow’s patented natural biologic technology made from mustard seed that acts as a bio-pesticide. MustGrow’s granular product is a United States EPA-approved organic solution that uses the mustard seed’s natural defence mechanism to protect plants from pests and diseases. Approximately CDN $10 million has been spent and over 110 independent tests completed, validating MustGrow’s safe and effective granular product. This product, which contains the same active ingredients as CannaProtector(R), is EPA-approved across all key U.S. states as a fertilizer and pesticide (currently limited to fertilizer in California) and is designated by Health Canada’s PMRA (Pest Management Regulatory Agency) as a fruit & vegetable bio-pesticide and fertilizer. MustGrow is positioning CannaProtector(R) as an effective pre-plant soil treatment, reducing the chance for any soil introduced to a greenhouse to bring in pests and diseases. The company expects its bio-pesticide will help licensed cannabis producers control the same conditions addressed in fruit and vegetable crops. The company has approximately 25.0 million basic common shares issued and outstanding and approximately 36.9 million on a fully diluted basis. For more information, visit the company’s website at www.Mustgrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://cnw.fm/MGRO

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Former FDA Boss Calls for Federal Regulation of Marijuana Markets

On Monday, Scott Gottlieb, the former Food and Drug Administration Commissioner, said that the federal government should be given the authority to regulate states’ marijuana programs.

In a CNBC appearance, Scott Gottlieb said that the increase in vaping related lung illnesses calls for the need of a federal regulatory system that would give the agencies power to enforce industry standards on all facets of the legal cannabis market such as the potency of THC and the proper methods of consumption.

Although the official was previously not clear on the extent of federal government involvement citing that the vaping problems are due to conflicts between the state and federal laws– he did not say which would be his preferred policy fix. However, last week in a Wall Street Journal editorial, he provided some clarification by saying that federal drug scheduling laws for marijuana should be reformed to offer limited regulations and promote more research on cannabis.

During a TV interview, Gottlieb said that enforcing marijuana prohibition is not politically practicable anymore and that Congress should approve a federal law that allows the enactment of appropriate supervision by the regulatory authorities.

Although he is not in support of the legalization of recreational marijuana and if possible he would like it to shut down completely, the reality of the situation is that many states have already legalized it; thus, any federal system formed would have to accommodate recreational cannabis.

When he was asked if all the states would be in a position to implement all the regulations he has proposed, Gottlieb said no, because some states do not have the capacity nor the resources to control what is being sold in their legal dispensaries as well as shutting down the black market.

He said that for this to be possible, federal authorities are a necessity.

The regulatory model Gottlieb is envisioning is one where the FDA and agencies such as the Drug Enforcement Administration could control the potency of the products, the manufacturing process, the ingredients, and the purpose for which the products are made.

Gottlieb further added that by federalizing marijuana and allowing recreational consumption, they would be in a position where they can limit the types of cannabis products being sold, their potency, and the forms in which it can be consumed. However, he still thinks vaping products should be banned.

He said that the federal agencies should enact strict measures on medical cannabis while holding them to a higher standard and allowing recreational use of the product with lower concentrations of THC, which poses less harm that vaping e-liquids.

He concludes by saying that compromising is right where you allow some form of recreational consumption of marijuana, which is in low concentration in the states allowing it instead of leaving it as it is today where there are no federal laws governing marijuana in those state-legal markets.

Industry analysts believe that companies like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) could be seeing lots of sense in the proposals of the former FDA chief.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Ruling Party in Scotland Supports Decriminalizing Drugs

On Sunday, Scottish National Party delegates, in a unanimous vote, approved a resolution calling for the decriminalization of drug possession and consumption.

The lawmakers representing the Scottish National Party, which is the third-largest party in the UK Parliament, in a conference in Aberdeen, argued that the parliament should remove criminal charges from drug offenses, and addiction should be addressed as a public health problem so as to control the overdose crisis in Scotland.

The resolution is an amendment to the 1971 Misuse of Drugs Act which states that we are in the 21^st century and the current law is not apt; therefore, a provision should be added that permits removal of criminal penalties for possession and consumption of controlled medicine such as marijuana so that physicians can use it as treatment for those who need it.

The SNP Members of Parliament introduced the measure. These include Tommy Sheppard, Ronnie Cowan, and Alison Thewliss.

According to Sheppard, instead of the Scotland law enforcement agencies focusing on the organized criminals at the top, their primary focus is on the weak and vulnerable.

If the UK government does not pursue the proposed reform, then it should give the power to Scotland because they will take the necessary steps to approve the motion, added Sheppard.

Many people who have experienced trauma most often self-medicate, which eventually leads to addiction, notes Cowan.

Cowan said that decriminalization places drugs in a health area such as dispensary, thus demystifying the medicine. He further added that drug laws are all about one’s mindset, and once the drug is decriminalized, the mindset changes, and this allows you as a physician to treat people as human beings, and as a result, the recovery process is started.

Conferences held in the past by the Scottish National Party had seen the approval of proposed drug reforms, such as establishing safe consumption sites that would help people transition into treatment, thus, preventing overdoses, Common Space Reports. The UK Parliament has resisted such harm reduction policies, and this has frustrated reform advocates.

A Royal Commission whose work is to review the country’s drug laws if voted by the majority will be launched, announced the Labour Party last month.

Thewliss said that the UK government’s attitude toward Scotland’s drug emergency is inexcusable. He added that while the Tories at Westminster take no action, hundreds of people are dying on the street while the public is at risk of improper disposal of needles and increased transmission of blood-borne diseases.

Mhairi Hunter, the Glasgow Councillor, while at the conference, said that challenging the stigma around addiction is the same as challenging the laws criminalizing addiction.

In the U.S, lawmakers are still focused on reforming marijuana laws. According to a survey released earlier this month, about 55% of Americans support decriminalization of marijuana possession and consumption. In the course of their presidential campaign, candidate Pete Buttigieg and Tulsi Gabbard voiced their support for the policy.

Analysts think marijuana companies like Willow Biosciences Inc. (CSE: WLLW) and Youngevity International Inc. (NASDAQ: YGYI) would want the Scottish view to be adopted in more jurisdictions, especially by the U.S. federal government.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – VPR Brands LP (VPRB) CEO Purchases Significant Personal Shares in Company

VPR Brands (OTCQB: VPRB), a multivertical, tiered, technology holding company, continues to focus on building first-rate brands in the nicotine and cannabis marketplaces. An article discussing the company reads, “VPR Brands’ product family includes vaporizers and accessories for essential oils, cannabis concentrates and extracts, and e-cigarettes that contain nicotine. For investors, the company’s focus is really a fundamental one — to keep adding products and distribution to boost sales and profits. This emphasis helped VPRB attain its revenue achievements in 2018 and so far in 2019. . . . The company’s experienced and forward-thinking management is also driving its growth. CEO, president and chairman Kevin Frija recently showed his faith in the company’s direction and strategic initiatives by purchasing a significant number of shares of VPR Brands. Investment analysts often correlate such personal investment from internal leadership with a company’s future potential.”

To view the full article, visit http://cnw.fm/XVh2u

About VPR Brands LP

VPR Brands is a technology company whose assets include issued U.S. and Chinese patents for atomization-related products including technology for medical-marijuana vaporizers and electronic-cigarette products and components. The company is also engaged in product development for the vapor or vaping market including e-liquids. Vaporizers and electronic cigarettes, also known as e-cigarettes, are devices that deliver nicotine and/or cannabis through atomization or vaping without smoke and other chemical constituents typically found in traditional products. For more information, visit the company’s website at www.VPRBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://cnw.fm/VPRB

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – Zenabis Global Inc. (TSX: ZENA) Posts Operational Update

Zenabis Global (TSX: ZENA) recently issued an update regarding its facility construction and licensing activities as well as the company’s cannabis production results. Among other highlights, the company reported a cultivation output of 1,996 kg of dried cannabis in August 2019, surpassing its revised forecast output of 1,579 kg by more than 26%. The company remains focused on advancing the construction underway at Zenabis Langley, which is anticipated to reach a total annual cultivation capacity of 143,200 kg upon completion of licensing. “August output was more than 60% greater than any prior month. Through to the end of October we expect the variety of cultivation approaches and rapid scale-up of the facility to result in significant room by room variance, after which we expect to achieve steady-state yields for each cultivar at Zenabis Atholville. We expect general steady-state operations in Atholville by December of 2019,” Zenabis CEO Andrew Grieve stated in the news release.

To view the full press release, visit http://cnw.fm/5WV7i

About Zenabis

Zenabis is a significant Canadian licensed cannabis cultivator of medical and recreational cannabis, and a propagator and cultivator of floral and vegetable products. Zenabis employs staff coast-to-coast, across facilities in Atholville, New Brunswick; Delta, Aldergrove, Pitt Meadows and Langley, British Columbia; and Stellarton, Nova Scotia. In addition to gaining technologically advanced knowledge of plant propagation, the recent addition of state-of-the-art greenhouses in Langley, Pitt Meadows and Aldergrove provides Zenabis with 3.5 million square feet of facility space that can, if fully converted, be dedicated to cannabis production. If all facility space at Zenabis Atholville, Zenabis Stellarton and Zenabis Langley is fully converted and dedicated to production, Zenabis will own, and have access to 635,000 square feet of high quality indoor cannabis production space, as well as 2.1 million square feet of greenhouse cannabis production space at its Langley facility, with this production strategically positioned on Canada’s coasts. Zenabis expects these facilities to have an annual design capacity of 143,200 kg of dried cannabis under its existing capital plan. These facilities, if fully built out and converted for cannabis production, would have an annual design capacity to yield approximately 490,800 kg of dried cannabis annually, for both national and international market distribution. An additional 700,000 square feet of greenhouse space will be used to continue the existing propagation business and produce industrial hemp, and can be converted to cannabis production at such a time that is beneficial to the strategic position of the Company. The Zenabis brand name is used in the cannabis medical market, while the Namaste and Blazery brand names are used in the cannabis adult-use recreational market, and the True Büch brand name is used for Zenabis’ kombucha products. For more information, visit the company’s website at www.Zenabis.com.

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com